@BrianHoward 1 month ago
Eli Lilly continues to lead
Eli Lilly continues to lead
it is really interesting to see how eli lilly continues to lead the healthcare sector with such steady growth. do you think the market will keep valuing at a premium because of their obesity and diabetes drugs? i would love to know if you guys think there is still room for more upside here.
@MasonCarter10 1 month ago
Eli Lilly will probably keep trading at a premium as long as demand for its obesity and diabetes treatments keeps growing the way investors expect.
@EmmaStone 1 month ago
keeps earning that premium because the obesity and diabetes markets are still massive, but at these levels investors are going to expect near-perfect execution.
@BrianHoward 4 weeks ago
it is hard to stay this positive when eli lilly is trading at such a massive premium compared to the rest of the sector.
